CD19 antibody | Bu12
Filter by Application:F Reset
Mouse anti Human CD19:FITC
- Product Type
- Monoclonal Antibody
|Mouse anti Human CD19 antibody, clone Bu12 recognizes human CD19, a 95 kDa cell surface glycoprotein, which is expressed on cells of the B cell lineage and follicular dendritic cells but absent on plasma cells. CD19 is an important signal transduction molecule which is involved in the regulation of B lymphocyte development, activation and differentiation.|
- Target Species
- Product Form
- Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC) - liquid
- Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
0.09% Sodium Azide (NaN3) 1% Bovine Serum Albumin
- Human EB-4 Burkitt lymphoma cell line
- Approx. Protein Concentrations
- IgG concentration 0.1mg/ml
- Fusion Partners
- Spleen cells from immunized mice were fused with cells from the X63 AG8 653 plasmacytoma
- Max Ex/Em
Fluorophore Excitation Max (nm) Emission Max (nm) FITC 490 525
- For research purposes only
- 12 months from date of despatch
Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended. This product is photosensitive and should be protected from light.
|Application Name||Verified||Min Dilution||Max Dilution|
- Flow Cytometry
- Use 10ul of the suggested working dilution to label 1x106 cells in 100ul.
How to Use the SpectraviewerWatch the Tool Tutorial Video ▸
- Start by selecting the application you are interested in, with the option to select an instrument from the drop down menu or create a customized instrument
- Select the fluorophores or fluorescent proteins you want to include in your panel to check compatibility
- Select the lasers and filters you wish to include
- Select combined or multi-laser view to visualize the spectra
References for CD19 antibody
Smith SH et al. (1991) Activation of human B cells through the CD19 surface antigen results in homotypic adhesion by LFA-1-dependent and -independent mechanisms.
Immunology. 73 (3): 293-7.
Callard, R.E. et al. (1992) CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
J Immunol. 148 (10): 2983-7.
Zhou, L. and Tedder, T. (1993) CD19 Workshop panel report.
In leucocyte Typing V. White cell differentiation antigens. Oxford University press. p507 – 509.
Callard, R.E. et al. (1995) CD40 cross-linking inhibits specific antibody production by human B cells.
Int Immunol. 7 (11): 1809-15.
Flavell, D.J. et al. (1995) Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours.
Br J Cancer. 72 (6): 1373-9.
Thornton, C.A. et al. (2002) Expression of CD21 and CD23 during human fetal development.
Pediatr Res. 52 (2): 245-50.
Vallera, D. A. et al. (2004) Radiotherapy of CD19 expressing Daudi tumors in nude mice with Yttrium-90-labeled anti-CD19 antibody.
Cancer Biother Radiopharm. 19 (1): 11-23.
Always be the first to know.
When we launch new products and resources to help you achieve more in the lab.Yes, sign me up